30,138 Shares in Spero Therapeutics, Inc. (NASDAQ:SPRO) Acquired by XTX Topco Ltd
XTX Topco Ltd acquired a new stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 30,138 shares of the company’s stock, valued at approximately $31,000. XTX Topco Ltd owned approximately 0.06% of Spero Therapeutics at the end […]
